Live Breaking News & Updates on Clinical Overview

Stay updated with breaking news from Clinical overview. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ultomiris regulatory submission accepted under FDA Priority Review in the US for adults with generalised myasthenia gravis

Submission based on positive Phase III trial in which Ultomiris significantly improved functional activities as measured by Myasthenia Gravis-Activities of Daily Living Profile ....

United States , Kuldigas Novads , United Kingdom , Republic Of Ireland , Marc Dunoyer , National Organization For Rare Disorders , Company On Twitter , Drug Administration , Alexion Pharmaceuticals Inc , Investor Relations Team , European Union , National Institutes Of Neurological Disorders , York Academy Of Sciences , Myasthenia Gravis Activities , Daily Living , Biologics License Application , Priority Review , Prescription Drug User Fee Act , Rare Disease , Chief Executive Officer , North America , Daily Living Profile , Myasthenia Gravis Foundation , America Clinical Classification Class , Astrazeneca Rare Disease , Alexion Pharmaceuticals ,

UCB announces positive Phase 3 results for rozanolixizumab in generalized myasthenia gravis

/PRNewswire/ UCB, a global biopharmaceutical company, today announced positive topline results from the Phase 3 MycarinG study1 evaluating rozanolixizumab,. ....

United States , Bruxelles Capitale , Seanm Healey , Samantha Masterson , Natalie Jones , Antje Witte , Laurent Schots , University Health Network , Brand Communications , Rare Disease Communications , University Of Toronto , Myasthenia Gravis Foundation Of America , European Union , Division Of Neurology , Corporate Communications , Lancet Reg Health West Pac , Myasthenia Gravis Activities , Daily Living , Professor Vera Bril , Lead Investigator , Neuromuscular Section , Chief Executive Officer , Myasthenia Gravis Foundation , Chief Medical Officer , Generalized Myasthenia Gravis , Daily Living Profile ,

Guidance for licensing electronic cigarettes and other inhaled nicotine-containing products as medicines

Guidance on how to licence electronic cigarettes and other inhaled nicotine-containing products (NCPs) as medicines in the UK. ....

United Kingdom , Northern Ireland , Great Britain , Elizabeth Baker , Efua Anno , Health Ministers , European Commission In Eudralex Volume , Competent Authority , European Commission , Association Of Great Britain , European Medicines Agency , Advertising Standards Authority , Committee On Toxicity , United Kingdom Medical Device Regulations , Products Regulations , Tobacco Products , Nicotine Inhaling Products , Human Medicines Regulation , Good Pharmacovigilance , Eudralex Volume , Legislation Notice , Common Technical Document , Day Procedure , British Pharmacopoeia , Good Manufacturing Practice , European Pharmacopoeia ,